Company Data
Curis Inc.
Ticker
CRIS
Current Price
$1.08 -5.26%
Market Cap
$14.8M
Price Target
Refer to Report
Volume
126.4K
52wk Range
$0.771 - $3.18
Overview
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.